Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Gyrodyne Company of America Inc (GYRO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/31/2025: GYRO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -100% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/31/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.30M USD | Price to earnings Ratio 46.24 | 1Y Target Price - |
Price to earnings Ratio 46.24 | 1Y Target Price - | ||
Volume (30-day avg) 750 | Beta 0.57 | 52 Weeks Range 7.65 - 11.96 | Updated Date 04/2/2025 |
52 Weeks Range 7.65 - 11.96 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.18 |
Earnings Date
Report Date 2025-03-26 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin -137.05% | Operating Margin (TTM) -121.3% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 46.24 | Forward PE - | Enterprise Value 12405168 | Price to Sales(TTM) 6.69 |
Enterprise Value 12405168 | Price to Sales(TTM) 6.69 | ||
Enterprise Value to Revenue 2.59 | Enterprise Value to EBITDA -8.07 | Shares Outstanding 2199310 | Shares Floating 662461 |
Shares Outstanding 2199310 | Shares Floating 662461 | ||
Percent Insiders 29.37 | Percent Institutions 37.02 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Gyrodyne Company of America Inc
Company Overview
History and Background
Gyrodyne Company of America Inc. was founded in 1946 as a developer of coaxial helicopter technology. It later shifted its focus to real estate, specifically medical office properties and commercial properties in Long Island, New York.
Core Business Areas
- Real Estate: Gyrodyne owns, manages, and leases medical office and commercial properties. This constitutes their primary business segment. They focus on the Long Island, New York market.
Leadership and Structure
As of latest information available, Dr. Robert J. Witmer is Chairman and CEO. The company has a small executive team and operates with a relatively lean organizational structure. Information on specific executive compensation or detailed org chart structure has not been easily available.
Top Products and Market Share
Key Offerings
- Medical Office and Commercial Property Leasing: Gyrodyne leases space in its properties to medical professionals and other commercial tenants. Market share data related specifically to Gyrodyne's Long Island real estate is not publicly available. Competitors include other real estate companies and REITs operating in the Long Island market, such as RXR Realty and Rechler Equity Partners.
Market Dynamics
Industry Overview
The medical office and commercial real estate market is influenced by factors like economic growth, healthcare spending, interest rates, and demographic trends. Demand for medical office space is generally stable due to consistent healthcare needs, but commercial real estate can be cyclical and impacted by economic downturns.
Positioning
Gyrodyne is a relatively small player in the real estate market. Its competitive advantage lies in its established presence in the Long Island area and its specialized focus on medical office properties.
Total Addressable Market (TAM)
The TAM for medical office and commercial real estate in Long Island is substantial, estimated in the billions of dollars annually. Gyrodyne's positioning gives it a small piece of this TAM but the company size limits it's overall potential.
Upturn SWOT Analysis
Strengths
- Established presence in Long Island
- Focus on medical office properties
- Experienced management team (as of information available)
Weaknesses
- Small size and limited resources
- Geographic concentration (Long Island)
- Lack of diversification
- Reliance on property rentals
Opportunities
- Acquisition of additional properties
- Expansion into related services (e.g., property management)
- Potential for development of new medical office buildings
- Strategic partnerships with healthcare providers
Threats
- Economic downturns impacting commercial real estate demand
- Increased competition from larger real estate companies
- Rising interest rates increasing borrowing costs
- Changes in healthcare regulations affecting medical office space needs
- Property taxes
Competitors and Market Share
Key Competitors
- RXR Realty (Private)
- Rechler Equity Partners (Private)
- SL Green Realty Corp (SLG)
Competitive Landscape
Gyrodyne faces intense competition from larger, more diversified real estate companies. Its advantages include its local expertise and focus on medical office properties. Its disadvantages include its limited scale and geographic concentration.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Analyze historical revenue and earnings growth rates. Assess the company's track record of acquiring or developing new properties.
Future Projections: Analyst estimates for Gyrodyne's future growth are limited due to its small size and relatively niche focus. Review company statements and industry trends to form your own projections.
Recent Initiatives: Check recent press releases and SEC filings for information on strategic initiatives, such as property acquisitions or development projects.
Summary
Gyrodyne Company of America Inc. is a small real estate company specializing in medical office properties in Long Island. Its strengths lie in its established local presence, while its weaknesses include its limited size and geographic concentration. Future success depends on its ability to acquire and develop new properties, and managing competition within the market.
Similar Companies
SLG
SL Green Realty Corp
SLG
SL Green Realty Corp
SLGL
Sol Gel Technologies Ltd
SLGL
Sol Gel Technologies Ltd
SLGN
Silgan Holdings Inc
SLGN
Silgan Holdings Inc
Sources and Disclaimers
Data Sources:
- SEC Filings (10-K, 10-Q), Company Website, Public Financial Data Providers, Press Releases
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Gyrodyne Company of America Inc
Exchange NASDAQ | Headquaters Saint James, NY, United States | ||
IPO Launch date 1995-08-18 | President, CEO, CFO & Treasurer Mr. Gary Jay Fitlin | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 6 | Website https://www.gyrodyne.com |
Full time employees 6 | Website https://www.gyrodyne.com | ||
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.